Radio-opaque contrast agents for liver cancer targeting with KIM during radiation therapy (ROCK-RT): an observational feasibility study

Authors

Paul Keall (ORCID: https://orcid.org/0000-0003-4803-6507)
Adam Mylonas (ORCID: https://orcid.org/0000-0001-6941-383X)
Nicholas Hardcastle (ORCID: https://orcid.org/0000-0001-7796-8472)
Richard Khor (ORCID: https://orcid.org/0000-0002-7057-2747)
Peter B. Greer (ORCID: https://orcid.org/0000-0001-7494-4029)
C. Sengupta (ORCID: https://orcid.org/0000-0002-8271-9777)
Doan Trang Nguyen (ORCID: https://orcid.org/0000-0003-1581-0359)
Prabhakar Ramachandran
David Pryor (ORCID: https://orcid.org/0000-0003-2574-2476)
Yuvnik Trada (ORCID: https://orcid.org/0000-0001-7935-6904)
Natalie Plant
Yoo Young Lee (ORCID: https://orcid.org/0000-0003-4325-349X)
Shona Silvester
Wei Wang (ORCID: https://orcid.org/0000-0002-1710-0919)
Venkatakrishnan Seshadri

Institutions

The University of Sydney (AU)
Peter MacCallum Cancer Centre (AU)
Princess Alexandra Hospital (AU)
Cancer Australia (AU)
Calvary Mater Newcastle Hospital (AU)
Olivia Newton-John Cancer Wellness & Research Centre (AU)
Austin Health (AU)

Publication Details

Journal: Radiation Oncology
Published: 2024-10-08
DOI: https://doi.org/10.1186/s13014-024-02524-4
Primary Topic: Hepatocellular Carcinoma Treatment and Prognosis
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Cancer Research Institute
Cancer Institute NSW
National Health and Medical Research Council

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Radio-opaque contrast agents for liver cancer targeting with KIM during radiation therapy (ROCK-RT): an observational feasibility study

Paul Keall, Adam Mylonas, Nicholas Hardcastle, Richard Khor et al.

Oct 8, 2024

Radiation Oncology

Hepatocellular Carcinoma Treatment and Prognosis

article

Radio-opaque contrast agents for liver cancer targeting with KIM during radiation therapy (ROCK-RT): an observational feasibility study

Paul Keall, Adam Mylonas, Nicholas Hardcastle, Richard Khor, Peter B. Greer, C. Sengupta, Doan Trang Nguyen, Prabhakar Ramachandran, David Pryor, Yuvnik Trada, Natalie Plant, Yoo Young Lee, Shona Silvester, Wei Wang, Venkatakrishnan Seshadri

October 8, 2024article en

Abstract

No abstract available for this paper.

Radiation OncologyVol. 19(1)

The University of Sydney (AU), Peter MacCallum Cancer Centre (AU), Princess Alexandra Hospital (AU), Cancer Australia (AU), Calvary Mater Newcastle Hospital (AU), Olivia Newton-John Cancer Wellness & Research Centre (AU), Austin Health (AU)

National Cancer Research Institute, Cancer Institute NSW, National Health and Medical Research Council

Good health and well-being

Openalex Percentile: Top 72%

Hepatocellular Carcinoma Treatment and Prognosis

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Radio-opaque contrast agents for liver cancer targeting with KIM during radiation therapy (ROCK-RT): an observational feasibility study — Paul Keall, Adam Mylonas, et al. · Radiation Oncology (2024) | TGRS Research Map | TGRS